Jerry J. Meng

1.2k citations
7 papers · 1.0k · 1 hit paper · h-index 7

Impact in

Papers in

    • Heat shock proteins research 2
    • Biochemical and Molecular Research 1
    • Alzheimer's disease research and treatments 1

Jerry J. Meng

7 papers receiving 968 citations

Jerry J. Meng's Hit Papers

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) 2011 · 811 citations
8110+5+10Years since publication250500750

Peers

Jerry J. Meng
Comparison fields: 5 of 49
  • Computational Theory and Mathematics 125
  • Pulmonary and Respiratory Medicine 249
  • Organic Chemistry 160
  • Physiology 39
  • Molecular Biology 91
Replace Iriny Botrous with:
Iriny Botrous United States
Clive McCarthy Switzerland
Joseph T. Repine United States
Asako Nagata United States
Diane E. Gingrich United States
Michelle Tran‐Dubé United States
Robert Hart Bradbury United Kingdom
Ermes Vanotti Italy
Tara Rheault United States
S. Elaine Barrie United Kingdom
Jerry J. Meng relative to Iriny Botrous United States Iriny Botrous's profile →
Citations per field
00.5×2×3×4.3×
Iriny Botrous · 1×
Citations per year

Countries citing papers authored by Jerry J. Meng

Since Specialization
Citations

This map shows the geographic impact of Jerry J. Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry J. Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry J. Meng more than expected).

Fields of papers citing papers by Jerry J. Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry J. Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry J. Meng. The network helps show where Jerry J. Meng may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerry J. Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerry J. Meng Line = papers co-authored together Jerry J. Meng links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
Hit paper breakdown →
2011811
2 200492
3 200840
4 201134
5 200719
6 200816
7 200515

About Jerry J. Meng

Jerry J. Meng is a scholar working on Molecular Biology, Physiology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 7 papers that have together received 1.0k indexed citations. Recurring topics across this work include Heat shock proteins research (2 papers), Alzheimer's disease research and treatments (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Computational Theory and Mathematics (125 citations), Pulmonary and Respiratory Medicine (249 citations), Organic Chemistry (160 citations), Physiology (39 citations) and Molecular Biology (91 citations). Jerry J. Meng has collaborated with scholars based in United States. Frequent co-authors include Pei‐Pei Kung, Paul A. Rejto, Richard E. Showalter, Bin Li, J. Ernest Villafranca, Laura A. Pelletier, Darin L. Vanderpool, James Alexander Thomson, Charles R. Kissinger and Stephen A. Margosiak. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, Journal of Molecular Biology and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact